Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation

To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2022-12, Vol.170, p.146-153
Hauptverfasser: Imber, Brandon S., O'Dwyer, Elisabeth, Lobaugh, Stephanie, McBride, Sean M., Hopkins, Margaret, Kollmeier, Marisa, Gorovets, Daniel, Brennan, Victoria, Pike, Luke R.G., Gewanter, Richard, Mychalczak, Borys, Zhang, Zhigang, Schöder, Heiko, Zelefsky, Michael J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 153
container_issue
container_start_page 146
container_title Urology (Ridgewood, N.J.)
container_volume 170
creator Imber, Brandon S.
O'Dwyer, Elisabeth
Lobaugh, Stephanie
McBride, Sean M.
Hopkins, Margaret
Kollmeier, Marisa
Gorovets, Daniel
Brennan, Victoria
Pike, Luke R.G.
Gewanter, Richard
Mychalczak, Borys
Zhang, Zhigang
Schöder, Heiko
Zelefsky, Michael J.
description To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression. We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment. Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.
doi_str_mv 10.1016/j.urology.2022.08.035
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10576466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429522007798</els_id><sourcerecordid>2715441279</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</originalsourceid><addsrcrecordid>eNqFUcFu1DAQtRCILoVPAPnIJenYTpzkhKpVC0itWLXlbM0648WrbFzsZKX9e1x1WeDEZUaamfdm5j3G3gsoBQh9sS3nGIawOZQSpCyhLUHVL9hC1LIpuq6rX7IFQAdFJbv6jL1JaQsAWuvmNTtTWoi6knrB-mv0wxyJr3CaKI6Jrw98dX97yVdXD9yFyO_IzjHSOPFVDGnCifgSR0uRo8uIU9VOYXfgOPb8Hoc9bojfYe9x8mF8y145HBK9O-Zz9v366mH5pbj59vnr8vKmsErpqajJgWpl1ZHDWrlKNVitUYJb5380gCUNTZtjU6HVtFaidT3lguyr3qlGnbNPz7yP83pHvc1HRxzMY_Q7jAcT0Jt_O6P_YTZhbwTUja60zgwfjwwx_JwpTWbnk6VhwJHCnIxssm6VkE2XR-vnUZsFSJHcaY8A82SR2ZqjRebJIgOtyRZl3Ie_jzyhfnvy5wvKUu09RZOsp6x472NW2fTB_2fFL4n4p6c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2715441279</pqid></control><display><type>article</type><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</creator><creatorcontrib>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</creatorcontrib><description>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression. We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment. Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2022.08.035</identifier><identifier>PMID: 36115426</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Neoplasm Recurrence, Local - surgery ; Positron Emission Tomography Computed Tomography - methods ; Positron-Emission Tomography ; Prospective Studies ; Prostate-Specific Antigen ; Prostatectomy ; Prostatic Neoplasms - diagnostic imaging ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - surgery ; Salvage Therapy - methods ; Tomography, X-Ray Computed</subject><ispartof>Urology (Ridgewood, N.J.), 2022-12, Vol.170, p.146-153</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</citedby><cites>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</cites><orcidid>0000-0002-1281-5915</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2022.08.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36115426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imber, Brandon S.</creatorcontrib><creatorcontrib>O'Dwyer, Elisabeth</creatorcontrib><creatorcontrib>Lobaugh, Stephanie</creatorcontrib><creatorcontrib>McBride, Sean M.</creatorcontrib><creatorcontrib>Hopkins, Margaret</creatorcontrib><creatorcontrib>Kollmeier, Marisa</creatorcontrib><creatorcontrib>Gorovets, Daniel</creatorcontrib><creatorcontrib>Brennan, Victoria</creatorcontrib><creatorcontrib>Pike, Luke R.G.</creatorcontrib><creatorcontrib>Gewanter, Richard</creatorcontrib><creatorcontrib>Mychalczak, Borys</creatorcontrib><creatorcontrib>Zhang, Zhigang</creatorcontrib><creatorcontrib>Schöder, Heiko</creatorcontrib><creatorcontrib>Zelefsky, Michael J.</creatorcontrib><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression. We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment. Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</description><subject>Gallium Isotopes</subject><subject>Gallium Radioisotopes</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Positron-Emission Tomography</subject><subject>Prospective Studies</subject><subject>Prostate-Specific Antigen</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Salvage Therapy - methods</subject><subject>Tomography, X-Ray Computed</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcFu1DAQtRCILoVPAPnIJenYTpzkhKpVC0itWLXlbM0648WrbFzsZKX9e1x1WeDEZUaamfdm5j3G3gsoBQh9sS3nGIawOZQSpCyhLUHVL9hC1LIpuq6rX7IFQAdFJbv6jL1JaQsAWuvmNTtTWoi6knrB-mv0wxyJr3CaKI6Jrw98dX97yVdXD9yFyO_IzjHSOPFVDGnCifgSR0uRo8uIU9VOYXfgOPb8Hoc9bojfYe9x8mF8y145HBK9O-Zz9v366mH5pbj59vnr8vKmsErpqajJgWpl1ZHDWrlKNVitUYJb5380gCUNTZtjU6HVtFaidT3lguyr3qlGnbNPz7yP83pHvc1HRxzMY_Q7jAcT0Jt_O6P_YTZhbwTUja60zgwfjwwx_JwpTWbnk6VhwJHCnIxssm6VkE2XR-vnUZsFSJHcaY8A82SR2ZqjRebJIgOtyRZl3Ie_jzyhfnvy5wvKUu09RZOsp6x472NW2fTB_2fFL4n4p6c</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Imber, Brandon S.</creator><creator>O'Dwyer, Elisabeth</creator><creator>Lobaugh, Stephanie</creator><creator>McBride, Sean M.</creator><creator>Hopkins, Margaret</creator><creator>Kollmeier, Marisa</creator><creator>Gorovets, Daniel</creator><creator>Brennan, Victoria</creator><creator>Pike, Luke R.G.</creator><creator>Gewanter, Richard</creator><creator>Mychalczak, Borys</creator><creator>Zhang, Zhigang</creator><creator>Schöder, Heiko</creator><creator>Zelefsky, Michael J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1281-5915</orcidid></search><sort><creationdate>20221201</creationdate><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><author>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Gallium Isotopes</topic><topic>Gallium Radioisotopes</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Positron-Emission Tomography</topic><topic>Prospective Studies</topic><topic>Prostate-Specific Antigen</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Salvage Therapy - methods</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imber, Brandon S.</creatorcontrib><creatorcontrib>O'Dwyer, Elisabeth</creatorcontrib><creatorcontrib>Lobaugh, Stephanie</creatorcontrib><creatorcontrib>McBride, Sean M.</creatorcontrib><creatorcontrib>Hopkins, Margaret</creatorcontrib><creatorcontrib>Kollmeier, Marisa</creatorcontrib><creatorcontrib>Gorovets, Daniel</creatorcontrib><creatorcontrib>Brennan, Victoria</creatorcontrib><creatorcontrib>Pike, Luke R.G.</creatorcontrib><creatorcontrib>Gewanter, Richard</creatorcontrib><creatorcontrib>Mychalczak, Borys</creatorcontrib><creatorcontrib>Zhang, Zhigang</creatorcontrib><creatorcontrib>Schöder, Heiko</creatorcontrib><creatorcontrib>Zelefsky, Michael J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imber, Brandon S.</au><au>O'Dwyer, Elisabeth</au><au>Lobaugh, Stephanie</au><au>McBride, Sean M.</au><au>Hopkins, Margaret</au><au>Kollmeier, Marisa</au><au>Gorovets, Daniel</au><au>Brennan, Victoria</au><au>Pike, Luke R.G.</au><au>Gewanter, Richard</au><au>Mychalczak, Borys</au><au>Zhang, Zhigang</au><au>Schöder, Heiko</au><au>Zelefsky, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>170</volume><spage>146</spage><epage>153</epage><pages>146-153</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression. We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment. Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36115426</pmid><doi>10.1016/j.urology.2022.08.035</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1281-5915</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2022-12, Vol.170, p.146-153
issn 0090-4295
1527-9995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10576466
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Gallium Isotopes
Gallium Radioisotopes
Humans
Male
Neoplasm Recurrence, Local - surgery
Positron Emission Tomography Computed Tomography - methods
Positron-Emission Tomography
Prospective Studies
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - radiotherapy
Prostatic Neoplasms - surgery
Salvage Therapy - methods
Tomography, X-Ray Computed
title Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20Patterns%20by%20PSMA%20PET%20for%20Recurrent%20Prostate%20Cancer%20after%20Prostatectomy%20and%20Salvage%20Radiation&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Imber,%20Brandon%20S.&rft.date=2022-12-01&rft.volume=170&rft.spage=146&rft.epage=153&rft.pages=146-153&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2022.08.035&rft_dat=%3Cproquest_pubme%3E2715441279%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2715441279&rft_id=info:pmid/36115426&rft_els_id=S0090429522007798&rfr_iscdi=true